Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Perturbagen Concentration Perturbagen Conc Unit Biological Replicate ID Relative Cell Count Normalized Growth Rate Inhibition Value Nominal Division Rate
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
1.6
uM
7875.018
0.8343 0.7928 1.6565
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
5000
uM
7874.018
0.0776 -0.5749 1.6506
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
200
uM
7874.018
0.7299 0.6527 1.6506
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
1000
uM
7874.018
0.6482 0.5380 1.6506
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
0.32
uM
7875.018
0.9399 0.9265 1.6565
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
0.0128
uM
7875.018
0.9910 0.9891 1.6565
MCF7
HR+
Luminal
CGC-11047
Polyamine analogue
0.064
uM
7875.018
0.9735 0.9679 1.6565